Results

Total Results: 2,617 records

Showing results for "mentioned".

121. Exhibit 5-7. Measure 7: Information about area (community) resources is offered by clinician (Wrap-Around Observation Form-2) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlas-ex57.html
     March 01, 2013 - Clinical-Community Relationships Measures (CCRM) Atlas Exhibit 5-7. Measure 7: Information about area (community) resources is offered by clinician (Wrap-Around Observation Form-2) Previous Page Next Page Table of Contents Clinical-Community Relationships Measures (CCRM) Atlas Introduction Ackno…

122. Tool: Formative Feedback | Agency for Healthcare Research and Quality
     www.ahrq.gov/teamstepps-program/curriculum/mutual/tools/feedback.html
     June 01, 2023 - person receiving feedback will be better able to correct or modify performance if specific actions are mentioned

123. AHRQ Webinar: on Leveraging Digital Health Technologies to Address the Needs of Underserved Populations - Q&As (pdf file)
     digital.ahrq.gov/sites/default/files/docs/technologies-underserved-populations-qas-02282023.pdf
     February 28, 2023 - QUESTION: In first presentation, the presenter mentioned soft referrals. What are warm referrals? … In terms of the food analysis I mentioned, we did not find evidence that "help seeking" was higher/lower … And it's often harder to recruit the patients, as I mentioned. … QUESTION: In first presentation, the presenter mentioned soft referrals. What are warm referrals? … QUESTION: You mentioned staff reluctance to screening.

124. Disposition of Comments for CER 162 Diagnosis of Celiac Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
     January 28, 2016 - (This is briefly mentioned at the conclusion of the Executive Summary and at the end of the manuscript … cost and acceptance of biopsy by asymptomatic subjects might make such studies prohibitive; this is mentioned … cost and acceptance of biopsy by asymptomatic subjects might make such studies prohibitive; this is mentioned … nearby and was a member of our technical expert panel, so we are aware of the important study you mentioned … One issue that is not mentioned is the need for even more accurate serologic tests that could supplant

125. SOPS™ Best Practices for Web-based SOPS Surveys Webcast Transcript (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/sops/events/webinar/bestpractices-web-sopssurveys-transcript.pdf
     June 12, 2019 - As I mentioned earlier, I am Theresa Famolaro, and I'll be serving as your moderator and speaker today … Famolaro, Slide 14 As Caren mentioned again as well, web-based survey response rates are not as high … June 2019 https://www.ahrq.gov/sops/index.html 8 As Theresa mentioned, you might want to use … Yount, Slide 54 In addition, and as Theresa mentioned, we have the SOPS databases. … Some of them Naomi mentioned.

126. Jun-2017-Cholesterol-Wg-Notes (doc file)
     cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
     January 01, 2017 - . · They can be mentioned in recommendation notifications as an exclusion, if implementers do not feel … · Another member advocated for the approach mentioned earlier – evaluating for Cirrhosis or an ALT

127. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
     January 15, 2016 - Peer reviewer #3 Discussion As mentioned in the review, the threshold for treatment is likely decreasing … TEP reviewer #2 Meta-analysis Page 20 I do not think that intralesional propranolol should be mentioned … or put in figure D; on the other hand triamcinolone is intralesional and should be mentioned in Figure … Prednisone – 29% These numbers are mentioned MANY times throughout the paper and I believe they are … Peer reviewer #4 Results The results section mentioned “a network meta-analysis” in many places – but

128. What every graduating resident needs to know about quality improvement and patient safety: a content analysis of 26 sets of ACGME milestones. | PSNet
     psnet.ahrq.gov/issue/what-every-graduating-resident-needs-know-about-quality-improvement-and-patient-safety
     March 29, 2023 - This analysis of specialty-specific milestones for graduate medical education found that about 40% mentioned

129. A.3-1 Patient Focus Group Guide | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/final-reports/crctoolkit/crctoolA31.html
     April 01, 2018 - As I mentioned, all information discussed today will be held in confidence. … As I mentioned, all information discussed today will be held in confidence. … As I mentioned, all information discussed today will be held in confidence.

130. Wrap-Around Observation Manual—Second Version | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlasapd3.html
     March 01, 2013 - Scoring Yes if it is mentioned or implied that the Care Coordinator has invited at least 2 key people … Note: If not mentioned at meeting, observer will ask parent if they were informed of the observer's

131. Improving Management of Test Results that Return After Hospital Discharge - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/k08hs018539-were-final-report-2014.pdf
     January 01, 2014 - to the discharging provider, who was able to select the pending tests she/he wanted to be mentioned … may have wanted to know who the follow-up provider was: We operated under the criteria that tests mentioned … The three reviewers independently abstracted all tests mentioned as having pending results in the discharge … The tests mentioned as pending in the discharge summaries were compared against tests which are truly … If a returning result belonged to a test which had been mentioned by the discharging provider as one

132. Practical-Methods-Care-Coordination-Slides (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/practical-methods-care-coordination-slides.pdf
     June 02, 2025 - comments you have for the panelists. 13 Next Steps  Event Materials: Slides and other resources mentioned

133. The potential of Twitter as a data source for patient safety. | PSNet
     psnet.ahrq.gov/issue/potential-twitter-data-source-patient-safety
     October 29, 2012 - These researchers reviewed 839 publicly available posts on Twitter that mentioned a possible patient

134. Trends in Neonatal Abstinence Syndrome Births in the United States (pdf file)
     hcup-us.ahrq.gov/reports/Trends_NeonatalAbstinenceSyndrome_Births_UnitedStates.pdf
     January 18, 2019 - Trends in Neonatal Abstinence Syndrome Births in the United States NAS Births in the U.S. 1 Updated: 01/18/2019 Estimates for 2016 include data from the following: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas…

135. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
     March 05, 2015 - Below the first Table 11, Table 12 is mentioned twice, one right after each other. … ES-8 please verify that the definitions of high, low, and standard dose estrogen used in table A is mentioned … Why is liver toxicity of vitamin E not mentioned as an agent-specific toxicity? … possibly pg. 5, Population) that studies involving women with breast cancer were excluded (first mentioned … does not allow referencing all the data of “lesser” quality, but certainly its existence should be mentioned

136. 20 years after To Err Is Human: a bibliometric analysis of ‘the IOM report’s’ impact on research on patient safety. | PSNet
     psnet.ahrq.gov/issue/20-years-after-err-human-bibliometric-analysis-iom-reports-impact-research-patient-safety
     July 15, 2020 - This bibliometric analysis found that the report has been mentioned in over 20,000 scientific publications

137. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/867428/psn-pdf
     December 18, 2024 - Sarah Mossburg: You mentioned that falling can increase an individual’s fear of falling again. … approach before trying to improve upon the existing evidence or create a new program Sarah Mossburg: You mentioned … Mossburg: In terms of the patient and family engagement and how you measure those process outcomes, you mentioned … Sarah Mossburg: You mentioned the importance of champions within units. … Sarah Mossburg: You mentioned the Fall TIPS Toolkit.

138. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/74021/psn-pdf
     October 25, 2021 - in establishing medication handling and dispensing, it's not always simple to ensure because, as we mentioned … We mentioned those Five Rights, verifying that the interpretation of the prescription you're getting … But going back to the issues that we mentioned, interoperability is a huge component of being able to … Lastly, we mentioned some barriers with the time available for dispensing and clinical services, such

139. Disposition of Comments for CER 170 Cultural Competence Health Disparities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
     January 01, 2020 - I believe this is the first time any results were mentioned, and the statement is very uninformative … Minimally this population should be mentioned in the research directions section Thank you, persons … Intersectionality is also mentioned throughout the review were relevant. … and discussed in the body of the text, tables, and reference list as well as mentioned in terms of … TEP 1 General As mentioned above, would suggest changing the storyline and chapter order to present

140. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - #4 Introduction Why are there no studies of gold included (p.19 list of DMARDs) (aside from the one mentioned … industry sponsored clinical trial, but so are many of the other studies cited where this fact is not mentioned … whether study sponsorship conflict of interest was used to evaluate the studies in which this was not mentioned … measure like the Pediatric ACR score (JRA core set), so I believe it should be evaluated or at least mentioned … One limitation that is not mentioned, however, which is that the existing evidence is almost entirely